SpeakPharma Interview With Pete Werth III

Mar 25, 2025 | News

Our Unmatched Efficiency and Track Record of Faster DMF Filings Give Our Customers a Critical Competitive Advantage Read Here: “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage” | Speak Pharma This...

Nitrosamines and Genotoxic Impurities

Feb 11, 2025 | News, White Papers

Please click the below link to view our most recent white paper that details the FDA’s guidance on nitrosamines/genotoxic impurities and how ChemWerth has developed a procedure to prevent our products from containing them. Nitrosamines and Genotoxic...

The ChemWerth Advantage

Feb 11, 2025 | News, White Papers

Please click the below link to view our most recent white paper explaining The ChemWerth Advantage and how we are able to get products to market at an unmmatched pace. The ChemWerth Advantage

Announcement of Leadership Change

Jun 17, 2024 | News

WOODBRIDGE, Conn. — ChemWerth, a leading supplier of generic active pharmaceutical ingredients (APIs), announced today that company founder Peter J. Werth has stepped down as president and CEO to spend more time on his entrepreneurial ventures and many philanthropic...

PharmaCompass Speak Pharma Interview

Jun 5, 2023 | News

With ChemWerth turning 40, what are your thoughts on the company’s journey? We have had an interesting journey thus far. After being founded in 1983, we filed our first Drug Master File (DMF) with the US Food and Drug Administration (FDA) in 1987. We have come a long...